• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
healthcare providers

Charles T. Quinn, MD, MS

Healthcare Provider
Medical Director
Cincinnati Children's Hospital
Erythrocyte Diagnostic Laboratory
3333 Burnet Avenue
Cincinnati, Ohio, United States

Dr. Quinn is Associate Professor of clinical pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical Center. He has a long-standing interest in sickle cell anemia and thalassemia. He serves on the ASH Committee on Educational Affairs and on the Publications Committee. Dr. Quinn is one of the resident pediatric hematologists at Cincinnati Children’s Hospital Medical Center.


Clinical Interests:

Sickle cell disease; thalassemia; hemoglobinopathies; anemia; autoimmune hemolytic anemia; disorders of red blood cells; iron overload and iron chelation; chronic transfusion therapy; immune thrombocytopenia (ITP); neutropenia; stroke.


Research Interests:

Epidemiology, pathophysiology, treatment and prevention of brain injury (structural and cognitive) in sickle cell disease; measurement of red blood cell turnover in sickle cell disease; identification and treatment of cardiomyopathy and nephropathy in sickle cell disease; treatment and prevention of pain (VOC) in sickle cell disease; MRI methods of iron quantitation; new agents for immune thrombocytopenia (ITP)


Representative Publications:

Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial

Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia

Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke

Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia

Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease

Acute silent cerebral infarction in children with sickle cell anemia

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.